DEUTSCHE BANK AG\ - STRONGBRIDGE BIOPHARMA PLC ownership

STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 79 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q3 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of STRONGBRIDGE BIOPHARMA PLC
ValueSharesWeighting
Q1 2021$155,000
+93.8%
56,215
+71.1%
0.00%
Q4 2020$80,000
+90.5%
32,851
+64.0%
0.00%
Q3 2020$42,000
-39.1%
20,036
+9.4%
0.00%
Q2 2020$69,000
+228.6%
18,313
+62.6%
0.00%
Q1 2020$21,000
-69.6%
11,263
-66.4%
0.00%
Q4 2019$69,000
+228.6%
33,513
+268.2%
0.00%
Q3 2019$21,000
-88.5%
9,102
-84.5%
0.00%
Q2 2019$182,000
+1922.2%
58,656
+2917.3%
0.00%
Q1 2019$9,000
-98.3%
1,944
-98.3%
0.00%
Q4 2018$518,000
-56.0%
115,700
-52.3%
0.00%
Q3 2018$1,176,000
-21.6%
242,510
-3.0%
0.00%
Q2 2018$1,500,000
+164.1%
250,074
+288.3%
0.00%
Q1 2018$568,000
+40.9%
64,409
+15.6%
0.00%
Q4 2017$403,000
+203.0%
55,711
+185.0%
0.00%
Q3 2017$133,000
-25.3%
19,551
-22.3%
0.00%
Q2 2017$178,000
+5833.3%
25,157
+1472.3%
0.00%
Q4 2016$3,0001,6000.00%
Other shareholders
STRONGBRIDGE BIOPHARMA PLC shareholders Q3 2020
NameSharesValueWeighting ↓
CAXTON CORP 5,376,039$47,309,00051.34%
Lyon Street Capital, LLC 3,182,149$28,162,0009.07%
Opaleye Management Inc. 1,590,000$14,071,0004.02%
Broadfin Capital, LLC 2,793,752$24,725,0003.85%
Vivo Capital, LLC 1,918,132$16,975,0002.40%
ARMISTICE CAPITAL, LLC 3,372,000$29,842,0002.28%
PRECEPT MANAGEMENT LLC 470,000$4,160,0001.73%
NEA Management Company, LLC 4,141,308$36,651,0001.63%
Harvest Capital Strategies LLC 825,000$7,301,0001.14%
Granite Point Capital Management, L.P. 567,895$5,026,0000.49%
View complete list of STRONGBRIDGE BIOPHARMA PLC shareholders